Santos da Silva Jorge

Chief Executive Officer, DirectorMoonLake Immunotherapeutics (MLTX) · full profile →Form 4 · filed Dec 10, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.0M
Net Open-Market Flow
-$3.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 9, 2025Sell(S)70K$14.49$1.0M2.9M
Dec 8, 2025Sell(S)130K$15.08$2.0M2.9M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-25-120106) within minutes of acceptance. Every field above traces to the original document. Verify it directly: